Considering opportunistic parasitic infections in COVID-19 policies and recommendations

Abhishek Mewara; Neeru Sahni; Amit Jain

doi:10.1093/trstmh/trab142

Considering opportunistic parasitic infections in COVID-19 policies and recommendations

Abhishek Mewara
, Neeru Sahni
, Amit Jain

Cleveland Clinic Abu Dhabi

Postgraduate Institute of Medical Education and Research

Research output: Contribution to journal › Review article › peer-review

8 Scopus citations

Abstract

The COVID-19 pandemic has led to a significant increase in the immunosuppressed population worldwide due to the disease pathology and extensive use of corticosteroids. This has subsequently increased the risk of opportunistic parasitic infections such as Toxoplasma gondii, Strongyloides stercoralis and other parasites in these patients. The reactivation of such parasites may remain unnoticed due to overlapping symptoms, the difficulty of diagnosis and lack of guidelines for opportunistic parasitic infections in COVID-19 management. Therefore, recommendations for systematic screening of high-risk patients in endemic regions and active research and surveillance to estimate the impact of these infections are required in COVID-19 policy guidelines.

Original language	English
Pages (from-to)	1345-1347
Number of pages	3
Journal	Transactions of the Royal Society of Tropical Medicine and Hygiene
Volume	115
Issue number	11
DOIs	https://doi.org/10.1093/trstmh/trab142
State	Published - 1 Nov 2021

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

COVID-19
SARS-CoV-2
corticosteroids
lymphopenia
opportunistic infections
parasitic infections

Access to Document

10.1093/trstmh/trab142

Cite this

@article{8d65e6daaec949fe9cc7ba9f00e11011,

title = "Considering opportunistic parasitic infections in COVID-19 policies and recommendations",

abstract = "The COVID-19 pandemic has led to a significant increase in the immunosuppressed population worldwide due to the disease pathology and extensive use of corticosteroids. This has subsequently increased the risk of opportunistic parasitic infections such as Toxoplasma gondii, Strongyloides stercoralis and other parasites in these patients. The reactivation of such parasites may remain unnoticed due to overlapping symptoms, the difficulty of diagnosis and lack of guidelines for opportunistic parasitic infections in COVID-19 management. Therefore, recommendations for systematic screening of high-risk patients in endemic regions and active research and surveillance to estimate the impact of these infections are required in COVID-19 policy guidelines.",

keywords = "COVID-19, SARS-CoV-2, corticosteroids, lymphopenia, opportunistic infections, parasitic infections",

author = "Abhishek Mewara and Neeru Sahni and Amit Jain",

year = "2021",

month = nov,

day = "1",

doi = "10.1093/trstmh/trab142",

language = "English",

volume = "115",

pages = "1345--1347",

journal = "Transactions of the Royal Society of Tropical Medicine and Hygiene",

issn = "0035-9203",

publisher = "Oxford University Press",

number = "11",

}

TY - JOUR

T1 - Considering opportunistic parasitic infections in COVID-19 policies and recommendations

AU - Mewara, Abhishek

AU - Sahni, Neeru

AU - Jain, Amit

PY - 2021/11/1

Y1 - 2021/11/1

N2 - The COVID-19 pandemic has led to a significant increase in the immunosuppressed population worldwide due to the disease pathology and extensive use of corticosteroids. This has subsequently increased the risk of opportunistic parasitic infections such as Toxoplasma gondii, Strongyloides stercoralis and other parasites in these patients. The reactivation of such parasites may remain unnoticed due to overlapping symptoms, the difficulty of diagnosis and lack of guidelines for opportunistic parasitic infections in COVID-19 management. Therefore, recommendations for systematic screening of high-risk patients in endemic regions and active research and surveillance to estimate the impact of these infections are required in COVID-19 policy guidelines.

AB - The COVID-19 pandemic has led to a significant increase in the immunosuppressed population worldwide due to the disease pathology and extensive use of corticosteroids. This has subsequently increased the risk of opportunistic parasitic infections such as Toxoplasma gondii, Strongyloides stercoralis and other parasites in these patients. The reactivation of such parasites may remain unnoticed due to overlapping symptoms, the difficulty of diagnosis and lack of guidelines for opportunistic parasitic infections in COVID-19 management. Therefore, recommendations for systematic screening of high-risk patients in endemic regions and active research and surveillance to estimate the impact of these infections are required in COVID-19 policy guidelines.

KW - COVID-19

KW - SARS-CoV-2

KW - corticosteroids

KW - lymphopenia

KW - opportunistic infections

KW - parasitic infections

UR - https://www.scopus.com/pages/publications/85119624671

U2 - 10.1093/trstmh/trab142

DO - 10.1093/trstmh/trab142

M3 - Review article

C2 - 34480170

AN - SCOPUS:85119624671

SN - 0035-9203

VL - 115

SP - 1345

EP - 1347

JO - Transactions of the Royal Society of Tropical Medicine and Hygiene

JF - Transactions of the Royal Society of Tropical Medicine and Hygiene

IS - 11

ER -

Considering opportunistic parasitic infections in COVID-19 policies and recommendations

Abstract

UN SDGs

Keywords

Access to Document

Other files and links

Fingerprint

Cite this